Title : Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWAS.

Pub. Date : 2020 Nov 4

PMID : 33143745






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Up to 40% of multiple sclerosis patients treated with interferon beta (IFNbeta) develop ADA, for which a genetic predisposition exists. N-(2-acetamido)iminodiacetic acid interferon beta 1 Homo sapiens